Infixion Bioscience
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3210 Merryfield Row, San Diego, Californ...Phone Number
(760) 855-1477Website
www.infixionbio.comRevenue
<$5 MillionIndustry
About Infixion Bioscience
iNFixion Bioscience is a drug discovery company focused on developing treatments for Neurofibromatosis Type 1 (NF1), a common genetic disorder affecting millions worldwide. The company aims to improve the lives of NF1 patients by addressing the root cause of the disease through innovative therapies that enhance the production of neurofibromin. Their approach not only seeks to alleviate symptoms but also to prevent disease progression, offering significant market potential in the rare disease sector. iNFixion targets a diverse clientele, including patients, caregivers, and healthcare professionals involved in NF1 management.Explore more
Infixion Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Infixion Bioscience
Compare insights from companies similar to Infixion Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Infixion Bioscience Tech Stack
A closer look at the technologies used by Infixion Bioscience
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Infixion Bioscience
Sign Up For FreeTo access detailed company insights
iNFixion Bioscience is a drug discovery company focused on developing treatments for Neurofibromatosis Type 1 (NF1), a common genetic disorder affecting millions worldwide. The company aims to improve the lives of NF1 patients by addressing the root cause of the disease through innovative therapies that enhance the production of neurofibromin. Thei... Read More
